Feature Article: Not All NIAID Initiatives Follow the Paylines
When NIAID sets a maximum dollar commitment for a particular initiative, applications are funded in score order until the initiative’s funding limit is reached. This approach precludes the use of paylines.
Feature Article: NIAID’s Ongoing Ebola Efforts in Congo, Elsewhere
It might be safe to say that you’re aware of the continuing Ebola epidemic in the Democratic Republic of the Congo, but perhaps less so of NIAID’s efforts to help stem the tide of outbreaks.
Feature Article: Refresher on Federal Law and NIH Policy on Select Agents
Before you apply for NIAID funding, you should know whether your research involves select agents, and if it does, the steps you will need to take to ensure public health safety.
Feature Article: Want To Learn About Cooperative Agreements? “U” Got It
A cooperative agreement is a support mechanism that NIH frequently uses for high-priority research areas that require substantial involvement from NIH staff for oversight, coordination, or facilitation.
A large percentage of the research NIAID funds is investigator-initiated, so if you come up empty searching for solicited request for applications announcements in your area of expertise, the next step is to plan an investigator-initiated application.
Feature Article: The Benefits of Being a Peer Reviewer
While helping others, you also benefit yourself since the insights you gain as a reviewer will likely aid you as an applicant as you get a look at what your peers want to see in an outstanding and well-written application.
Misunderstanding how the term "unsolicited" applies to funding opportunity announcements may result in your failing to meet our requirements for big grants.
Feature Article: Tips for Writing a Strong Multiple PI Leadership Plan
Reviewers will judge the Leadership Plan of an application with multiple principal investigators (PIs) for its scientific merit and whether it promotes enough coordination and communication among PIs.
Certain codes in your summary statement can indicate an award restriction or bar to award, which can block you from funding until you resolve underlying scientific review concerns about human subjects involvement, human subjects inclusion, or animal welfare in your application.
Feature Article: Taking a Long View of FY 2018 Application and Award Data
We lay out NIAID’s R01 and R21 application counts, award totals, success rates, and more over the past 20 years, considering these figures in relation to shifting NIH funding levels.
Feature Article: A Look at the First Advisory Council Meeting of 2019
Catch up on outcomes from the January 28 Advisory Council session, including presentations from NIAID Director Dr. Anthony Fauci and NIAID Division of Clinical Research Director Dr. Cliff Lane.
Feature Article: Find FY 2018 Application and Award Totals in the NIH Data Book
We lay out NIAID’s R01-equivalent and R21 application counts, award totals, and success rates over the last few years and make a few observations along the way.
Feature Article: Grant Coming to an End? Avoid and Survive a Funding Gap
Whether you're on your first grant or you have had decades of support, renewal is never guaranteed. By creating multiple streams of funding, you can sustain your lab even if you lose one grant.
Feature Article: Eligibility Requirements for Foreign Investigators and Institutions
Every funding opportunity announcement (FOA) includes information that specifically states whether the FOA allows foreign institutions to apply as the primary grantee or be a subcomponent on a different institution’s grant.
Feature Article: Small Businesses: Set Your Sights on Phase III
Although NIAID does not fund small businesses directly during Phase III private sector commercialization, we try to prepare grantees for success through programs tailored to Phase I and II awardees.
Feature Article: Access to Genomic Summary Results: Get up to Date on Updated Policy
The updated data management procedures under the Genomic Data Sharing policy allow unrestricted access to most NIH-supported studies for health and research purposes while considering potential risk to research participants.
Feature Article: NIAID Sets Interim Paylines for Most Activity Codes
We’ve now posted interim paylines for most applicable activity codes at NIAID Paylines, including training, fellowship, small business, and small research grant awards.
If you missed the September 17, 2018 meeting of NIAID’s Advisory Council, you can watch a videocast of remarks from NIAID Director Dr. Anthony Fauci and NIAID Division of Intramural Research Director Dr. Steven Holland, as well as open subcommittee sessions.
Feature Article: Update on TB RFI: NIAID Analyzes Responses, Finalizes Strategic Plan
Learn how NIAID staff incorporated community feedback into our strategic plan to advance tuberculosis research and development for the next five years and beyond.
Feature Article: Comment on Draft Updates to NIH's Clinical Trial Protocol Template
The Behavioral and Social Sciences Clinical Trials Template will inform an update to the Clinical e-Protocol Writing Tool, which applicants can use as a guide when preparing comprehensive clinical protocols for Phase 2 and 3 clinical trials.
Feature Article: Your Obligations Aren’t Over When Your Project Period Ends
Within 120 days of your project period’s end date, you must submit a Final Research Performance Progress Report, Final Federal Financial Report, and Final Invention Statement and Certification.